Value of endorectal MRI and MRS in patients with elevated prostate-specific antigen levels and previous negative biopsies to localize peripheral zone tumours

Crawford, 2003, Epidemiology of prostate cancer, Urology, 62, 3, 10.1016/j.urology.2003.10.013

Djavan, 2002, Repeat prostate biopsy: who, how and when? A review, Eur Urol, 42, 93, 10.1016/S0302-2838(02)00256-7

Roobol, 2003, European randomized study of screening for prostate cancer: achievements and presentation, BJU Int, 92, 117, 10.1111/j.1464-410X.2003.4698x.x

Djavan, 2001, Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop?, J Urol, 166, 1679, 10.1016/S0022-5347(05)65652-2

Lujan, 2004, Prostate cancer detection and tumor characteristics in men with multiple biopsy sessions, Prostate Cancer Prostatic Dis, 7, 238, 10.1038/sj.pcan.4500730

Hricak, 2004, The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomy, Cancer, 100, 2655, 10.1002/cncr.20319

Kaji, 1998, Localizing prostate cancer in the presence of postbiopsy changes on MR images: role of proton MR spectroscopic imaging, Radiology, 206, 785, 10.1148/radiology.206.3.9494502

Yu, 1999, Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging, Radiology, 213, 481, 10.1148/radiology.213.2.r99nv26481

Scheidler, 1999, Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging–clinicopathologic study, Radiology, 213, 473, 10.1148/radiology.213.2.r99nv23473

Coakley, 2002, Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging, Radiology, 223, 91, 10.1148/radiol.2231010575

Beyersdorff, 2002, Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging, Radiology, 224, 701, 10.1148/radiol.2243011553

Prando, 2005, Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience, Radiology, 236, 903, 10.1148/radiol.2363040615

Yuen, 2004, Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy, J Urol, 171, 1482, 10.1097/01.ju.0000118380.90871.ef

Amsellem-Ouazana, 2005, Negative prostatic biopsies in patients with a high risk of prostate cancer. Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool? A preliminary study, Eur Urol, 47, 582, 10.1016/j.eururo.2005.01.015

Wetter A, Hubner F, Lehnert T, et al. Three-dimensional 1H-magnetic resonance spectroscopy of the prostate in clinical practice: technique and results in patients with elevated prostate-specific antigen and negative or no previous prostate biopsies. Eur Radiol15:645.

Manenti, 2006, Magnetic resonance imaging of the prostate with spectroscopic imaging using a surface coil. Initial clinical experience, Radiol Med, 111, 22, 10.1007/s11547-006-0003-x

Terris, 1991, Determination of prostate volume by transrectal ultrasound, J Urol, 145, 984, 10.1016/S0022-5347(17)38508-7

Schricker, 2001, Dual-band spectral-spatial RF pulses for prostate MR spectroscopic imaging, Magn Reson Med, 46, 1079, 10.1002/mrm.1302

Tran, 2000, Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer, Magn Reson Med, 43, 23, 10.1002/(SICI)1522-2594(200001)43:1<23::AID-MRM4>3.0.CO;2-E

Kurhanewicz, 1996, Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging, Radiology, 200, 489, 10.1148/radiology.200.2.8685346

Zackrisson, 2004, The risk of finding focal cancer (less than 3mm) remains high on re-biopsy of patients with persistently increased prostate specific antigen but the clinical significance is questionable, J Urol, 171, 1487, 10.1097/01.ju.0000118052.59597.83

Zakian KL, Eberhardt S, Hricak H, et al. Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging—initial results. 2003;229:241.

Schiebler, 1989, Prostatic carcinoma and benign prostatic hyperplasia: correlation of high-resolution MR and histopathologic findings, Radiology, 172, 131, 10.1148/radiology.172.1.2472644

Fournier, 2004, Prostate cancer. Epidemiology. Risk factors. Pathology, Ann Urol (Paris), 38, 187, 10.1016/j.anuro.2004.07.001

Anastasiadis, 2006, MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies, Eur Urol, 50, 738, 10.1016/j.eururo.2006.03.007

Beyersdorff, 2005, MR imaging-guided prostate biopsy with a closed MR unit at 1.5T: initial results, Radiology, 234, 576, 10.1148/radiol.2342031887

Rabets, 2004, Prostate cancer detection with office based saturation biopsy in a repeat biopsy population, J Urol, 172, 94, 10.1097/01.ju.0000132134.10470.75

Futterer, 2006, Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging, Radiology, 241, 449, 10.1148/radiol.2412051866

Swindle, 2003, Pathologic characterization of human prostate tissue with proton MR spectroscopy, Radiology, 228, 144, 10.1148/radiol.2281011808